Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
GDS Holdings Ltd is an information technology services business based in the US. GDS shares (GDS) are listed on the NASDAQ and all prices are listed in US Dollars. GDS employs 1,878 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $34.19 |
|---|---|
| 52-week range | $19.83 - $77.96 |
| 50-day moving average | $29.57 |
| 200-day moving average | $43.27 |
| Wall St. target price | $51.10 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.30 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $34.19 from 2022-07-01
| 1 week (2022-06-27) | -2.34% |
|---|---|
| 1 month (2022-06-03) | 23.25% |
| 3 months (2022-04-04) | -23.12% |
| 6 months (2022-01-04) | -16.65% |
| 1 year (2021-07-02) | -55.26% |
|---|---|
| 2 years (2020-07-02) | -58.71% |
| 3 years (2019-07-03) | 38.45 |
| 5 years (2017-07-03) | 277.37% |
Valuing GDS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GDS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GDS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.4 billion.
The EBITDA is a measure of a GDS's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $8.4 billion |
|---|---|
| Operating margin TTM | 6.99% |
| Gross profit TTM | $1.8 billion |
| Return on assets TTM | 0.55% |
| Return on equity TTM | -4.99% |
| Profit margin | -18.41% |
| Book value | $131.33 |
| Market capitalisation | $6.6 billion |
TTM: trailing 12 months
We're not expecting GDS to pay a dividend over the next 12 months.
Over the last 12 months, GDS's shares have ranged in value from as little as $19.83 up to $77.96. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GDS's is 1.0749. This would suggest that GDS's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
GDS Holdings Limited, together with its subsidiaries, develops and operates data centers in the People's Republic of China. The company provides colocation services comprising critical facilities space, customer-available power, racks, and cooling; managed hosting services, including business continuity and disaster recovery, network management, data storage, system security, operating system, database, and server middleware services; managed cloud services; and consulting services. It serves cloud service providers, large Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. The company was founded in 2001 and is headquartered in Shanghai, the People's Republic of China. .
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.